Skip to main content

Evidence-Based Supplement Research

Evidence-Based Supplement Research

Lactobacillus rhamnosus GG and Reduced Erysipelotrichaceae Abundance

Doses used in studies

CFU/day: 12 billion (median 12 billion, IQR 12 billion–12 billion) — 1 study

Time to effect

Median: 8 weeks · IQR 8 weeks–8 weeks · Range 8 weeks–8 weeks — Reported in 1 of 1 study

1 of 1 paper

Effect of Lactobacillus rhamnosus GG Supplementation on Intestinal Inflammation Assessed by PET/MRI Scans and Gut Microbiota Composition in HIV-Infected Individuals.
- 2018-08-01
- Clinical Trial · n = 45
- Journal of acquired immune deficiency syndromes (1999) 78(4)
- - Caroline J Arnbjerg
  - Beate Vestad
  - Johannes R Hov
  - Karin K Pedersen
  - Sofie Jespersen
  - Helle H Johannesen
  - Kristian Holm
  - Bente Halvorsen
  - Eva Fallentin
  - Adam E Hansen
  - Theis Lange
  - Andreas Kjær
  - Marius Trøseid
  - Barbara M Fischer
  - Susanne D Nielsen
- PubMed: 29874201
- DOI: 10.1097/qai.0000000000001693
11 Insights on
- Reduced Erysipelotrichaceae Abundance
- High evidence
- Clinical
reduction of ... Erysipelotrichaceae (P = 0.037)
Effect
Beneficial
Effect size
Small
Significant
Yes
Dose
6 × 10^9 colony-forming units per capsule twice daily